Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children
Sponsor: Albert Schweitzer Hospital
A PHASE3 clinical study on Fever and Malaria, this trial is completed. The trial is conducted by Albert Schweitzer Hospital and has accumulated 6 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jul 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Albert Schweitzer Hospital
- Centre Muraz
- Centro de Investigacao em Saude de Manhica
- East African Network for Monitoring Antimalarial Treatment
- Institute of Tropical Medicine, Belgium
- Liverpool School of Tropical Medicine
- Mbarara University of Science and Technology
- Ministry of Health, Rwanda
- Tropical Diseases Research Centre, Zambia
- Uganda Malaria Surveillance Project
- University Hospital Tuebingen
- University of Barcelona
- University of Calabar
For direct contact, visit the study record on ClinicalTrials.gov .